| |
| |
|
| Insider
Information: |
Mason Michael B |
| Relationship: |
EVP & Pres., Lilly Dia... |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
39,284 |
|
|
Indirect Shares
|
957 |
|
|
| Direct
Value |
$28,872,561 |
|
|
|
Indirect Value
|
$703,366 |
|
|
| Total
Shares |
40,241 |
|
|
| Total
Value |
$29,575,928 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
EVP & Pres., Lilly Dia... |
2023-02-10 |
39,284 |
2023-02-10 |
957 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
EVP & Pres., Lilly Diabetes |
• – – |
2023-02-10 |
4 |
A |
$345.12 |
$2,768,898 |
D/D |
8,023 |
39,284 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP & Pres., Lilly Diabetes |
• – – |
2023-02-01 |
4 |
D |
$344.15 |
$1,010,080 |
D/D |
(2,935) |
31,261 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP & Pres., Lilly Diabetes |
• – – |
2023-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,690 |
34,196 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2022-02-09 |
4 |
A |
$243.27 |
$635,421 |
D/D |
2,612 |
27,506 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2021-02-08 |
4 |
A |
$205.77 |
$1,306,640 |
D/D |
6,350 |
24,894 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2020-09-01 |
4 |
D |
$148.39 |
$405,847 |
D/D |
(2,735) |
18,544 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2020-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,244 |
21,279 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2020-02-11 |
4 |
A |
$144.25 |
$834,486 |
D/D |
5,785 |
15,035 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2020-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
865 |
|
% |
|
| LLY |
Eli Lilly & Co |
Sr. VP & Pres., Lilly Diabetes |
• – – |
2020-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,250 |
|
% |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
